Ingredion interim CFO discloses equity holdings
Ingredion Inc's interim CFO and VP, Finance, Jason Payant, filed an initial Form 3 disclosing his existing equity holdings in the company.
Rhea-AI Filing Summary
Ingredion Inc's interim CFO and VP, Finance, Jason Payant, filed an initial Form 3 disclosing his existing equity holdings in the company. The filing lists several grants of employee stock options to buy common stock at exercise prices ranging from $87.12 to $130.57, with expirations between 2028 and 2035.
He also reports 5,161.037 shares of common stock held directly and 249.443 phantom stock units, each representing the right to receive one share of common stock. Footnotes clarify that the option awards vest in three equal annual installments on specified February dates.
Positive
- None.
Negative
- None.
Insider Trade Summary
10 transactions reported
Mixed
10 txns
Insider
Payant Jason
Role
Interim CFO & VP, Finance
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Options (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Options (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Options (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Options (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Options (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Options (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Options (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Options (Right to Buy) | -- | -- | -- |
| holding | Phantom Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Employee Stock Options (Right to Buy) — 18,201 contracts (Direct);
Phantom Stock — 249.443 contracts (Direct);
Common Stock — 5,161.037 shares (Direct)
Footnotes (9)
- F1. These options vested in three equal annual installments on February 6, 2019, 2020 and 2021.
- F2. These options vested in three equal annual installments on February 8, 2020, 2021 and 2022.
- F3. These options vested in three equal annual installments on February 4, 2021, 2022 and 2023.
- F4. These options vested in three equal annual installments on February 9, 2022, 2023 and 2024.
- F5. These options vested in three equal annual installments on February 16, 2023, 2024 and 2025.
- F6. These options vested in three equal annual installments on February 4, 2024, 2025 and 2026.
- F7. These options have vested and will vest in three equal annual installments on February 13, 2025, 2026 and 2027.
- F8. These options have vested and will vest in three equal annual installments on February 26, 2026, 2027 and 2028.
- F9. Each phantom stock unit represents the right to receive one share of common stock.
Key Figures
Direct common stock holdings: 5,161.037 shares
Phantom stock units: 249.443 units
Option exercise price: $130.30 per share
+3 more
6 metrics
Direct common stock holdings
5,161.037 shares
Total common stock directly held as of Form 3
Phantom stock units
249.443 units
Each unit represents right to one common share
Option exercise price
$130.30 per share
Employee stock options expiring February 5, 2028
Option exercise price
$91.85 per share
Employee stock options expiring February 7, 2029
Option exercise price
$87.12 per share
Employee stock options expiring February 9, 2031
Option exercise price
$130.57 per share
Employee stock options expiring February 26, 2035
Key Terms
Employee Stock Options (Right to Buy), Phantom Stock, phantom stock unit, exercise price, +1 more
5 terms
Employee Stock Options (Right to Buy) financial
"security_title": "Employee Stock Options (Right to Buy)""
Phantom Stock financial
"security_title": "Phantom Stock""
A phantom stock is a form of compensation that gives employees or executives the benefits of stock ownership, such as the increase in stock value, without actually giving them real shares. It acts like a promise to pay the employee the equivalent value of company stock later, often as a bonus or incentive. This allows companies to motivate and reward staff without diluting ownership or transferring actual shares.
phantom stock unit financial
"Each phantom stock unit represents the right to receive one share"
exercise price financial
"conversion_or_exercise_price": "108.3800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2035-02-26T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Ingredion (INGR) Form 3 filing for Jason Payant show?
The Form 3 shows Jason Payant’s existing equity stake in Ingredion. It lists his direct holdings of common stock, multiple employee stock option grants with specific exercise prices and expirations, and phantom stock units that each represent the right to receive one share of common stock.
What stock options are disclosed for Jason Payant in Ingredion’s Form 3?
The Form 3 lists several employee stock option grants to buy Ingredion common stock. Exercise prices range from $87.12 to $130.57 per share, with expiration dates from February 2028 through February 2035, giving a timetable for how long these options remain exercisable.
How do the phantom stock units in Ingredion (INGR) Form 3 work?
The filing states that each phantom stock unit represents the right to receive one share of common stock. Jason Payant holds 249.443 such units, which track Ingredion’s share value and are typically settled in shares according to plan terms, aligning compensation with shareholder outcomes.
Are there any buy or sell transactions in this Ingredion (INGR) Form 3?
The Form 3 reflects holdings rather than transactions, with transaction codes marked as unknown and no buy or sell direction indicated. It lists outstanding stock, options, and phantom units, serving as an initial snapshot of Jason Payant’s equity interests as a reporting officer.
When do Jason Payant’s Ingredion stock options vest according to the Form 3 footnotes?
Footnotes explain that various option grants vest in three equal annual installments on specific February dates. These vesting schedules span years such as 2019–2021, 2020–2022, and continuing through 2026–2028, defining when portions of each award become exercisable over time.
AI-generated analysis. How Rhea-AI works. Not financial advice.
